Vaccines

How is the business of making medicine changing in light of the COVID-19 pandemic?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

Can we reverse the effect of the ageing process on the immune system?

A clinical trial tracker aims to encourage international collaboration on COVID-19 drug development.

What’s the fastest route to a COVID-19 vaccine?

Under pressure to deliver results, how can the pharmaceutical industry handle the current COVID-19 crisis to help patients around the world?

How plants could speed up vaccine manufacture to tackle the COVID-19 pandemic.

The development of a CMV vaccine has been 50 years in the making.